BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 543513)

  • 41. Formation and detection of fibrinogen derived complexes.
    Latallo ZS
    Thromb Diath Haemorrh; 1975 Dec; 34(3):677-85. PubMed ID: 1209540
    [No Abstract]   [Full Text] [Related]  

  • 42. Precipitation of fibrin monomers and fibrin degradation products by ristocetin.
    Watanabe K; Tullis JL
    Am J Med Sci; 1978; 275(3):337-44. PubMed ID: 80134
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Glomerular fibrins, serum and urinary FDP fragments in kidney diseases in children].
    Uetsuji H; Taira K
    Nihon Jinzo Gakkai Shi; 1983 Jul; 25(7):826-9. PubMed ID: 6663849
    [No Abstract]   [Full Text] [Related]  

  • 44. Precipitation of fibrinogen, fibrinogen degradation products and fibrin monomer by histone H3.
    Gonias SL; Pasqua JJ; Greenberg C; Pizzo SV
    Thromb Res; 1985 Jul; 39(1):97-116. PubMed ID: 4035652
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Use of certain selective chemical precipitation reactions of serum proteins in the study of normal and pathological pregnancies].
    Morin P; Badin J; Abbou S; Yver AM; Ozil D
    J Gynecol Obstet Biol Reprod (Paris); 1977 Dec; 6(8):1077-90. PubMed ID: 75906
    [No Abstract]   [Full Text] [Related]  

  • 46. Fibronectin and cryoprecipitation.
    Garelli S; MeroĊ„i PL; Montani F; Invernizzi F
    Ric Clin Lab; 1986; 16(2):321-6. PubMed ID: 3787093
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Protamine interacts with the D-domains of fibrinogen.
    Okano K; Saito Y; Matsushima A; Inada Y
    Biochim Biophys Acta; 1981 Dec; 671(2):164-7. PubMed ID: 6173066
    [No Abstract]   [Full Text] [Related]  

  • 48. Catabolism of fibrinogen and its derivatives.
    Sherman LA
    Thromb Haemost; 1977 Dec; 38(4):809-22. PubMed ID: 341411
    [No Abstract]   [Full Text] [Related]  

  • 49. Comparison of different methods to measure fibrinogen concentration in canine plasma with respect to their sensitivity towards the fibrinogen degradation products X, Y and D.
    Mischke R; Menzel D; Wolling H
    Haemostasis; 2000; 30(3):131-8. PubMed ID: 11014963
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characterization of cryofibrinogen isolated from patients plasma.
    Stathakis NE; Karamanolis D; Koukoulis G; Tsianos E
    Haemostasis; 1981; 10(4):195-202. PubMed ID: 7250786
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cold aggregation properties of some macroglobulins.
    Bobrzecka K; Janicki K; Konieczny L
    Clin Chim Acta; 1969 Dec; 26(3):580-2. PubMed ID: 5358559
    [No Abstract]   [Full Text] [Related]  

  • 52. In vivo stability of cryoprecipitate fibrinogen.
    Sherman LA
    Transfusion; 1977; 17(1):59-61. PubMed ID: 841675
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Fibrinolytic activity of blood and urine in young children with acute pneumonia].
    Mamatkulov KhM; Abdullaeva MN
    Pediatriia; 1981; (8):14-6. PubMed ID: 7290832
    [No Abstract]   [Full Text] [Related]  

  • 54. [Relation between tumor necrosis factor secretion activity and serum FDP level in cancer patients: preliminary report].
    Ono H; Kikuchi S; Nakamura Y; Yamauchi A; Takahashi M; Machida T; Yoshida K
    Nihon Geka Gakkai Zasshi; 1989 Oct; 90(10):1818. PubMed ID: 2594012
    [No Abstract]   [Full Text] [Related]  

  • 55. Distribution of cold-insoluble globulin in plasma and tissues.
    Matsuda M; Yoshida N; Aoki N; Wakabayashi K
    Ann N Y Acad Sci; 1978 Jun; 312():74-92. PubMed ID: 291382
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chemical modification of fibrinogen and the effect on fibrin formation.
    Saito Y; Shimizu A; Matsushima A; Inada Y
    Ann N Y Acad Sci; 1983 Jun; 408():288-300. PubMed ID: 6575690
    [No Abstract]   [Full Text] [Related]  

  • 57. In vitro and in vivo effects of heparin on cryofibrinogen.
    Komp DM; Donaldson MH
    N Engl J Med; 1968 Dec; 279(26):1439-40. PubMed ID: 5722919
    [No Abstract]   [Full Text] [Related]  

  • 58. Determination of fibrinogen degradation products by immuno-enzymological assay.
    Soria J; Soria C
    Thromb Res; 1978 Jun; 12(6):1025-35. PubMed ID: 358481
    [No Abstract]   [Full Text] [Related]  

  • 59. Bithermic complement activation in cryoglobulinaemic serum.
    Rother U; Rother K; Flad HD; Miescher PA
    Eur J Clin Invest; 1972 Jan; 2(2):59-65. PubMed ID: 5027238
    [No Abstract]   [Full Text] [Related]  

  • 60. Hemostatic markers in heart disease.
    Yamamoto K; Ikesa U; Fukazawa H; Shimada K
    Am Heart J; 1998 Feb; 135(2 Pt 1):365-6. PubMed ID: 9489989
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.